Cycloalkyl substituted pyrimidinediamine compounds and their...

Details Cycloalkyl substituted pyrimidinediamine compounds and their... Cycloalkyl substituted pyrimidinediamine compounds and their...

2011-01-11

2011-01-11

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S323000

Reexamination Certificate

active

07868013

ABSTRACT:
The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.

REFERENCES:
patent: 5962312 (1999-10-01), Plowman et al.
patent: 5972676 (1999-10-01), Plowman et al.
patent: 6207401 (2001-03-01), Plowman et al.
patent: 6342503 (2002-01-01), Aldrich et al.
patent: 6593326 (2003-07-01), Bradbury et al.
patent: 6841579 (2005-01-01), Plowman et al.
patent: 6908920 (2005-06-01), Thomas et al.
patent: 7060827 (2006-06-01), Singh et al.
patent: 7173028 (2007-02-01), Dahmann et al.
patent: 7459301 (2008-12-01), Argade
patent: 7511137 (2009-03-01), Li
patent: 2003/0139435 (2003-07-01), Ahmed et al.
patent: 2003/0162802 (2003-08-01), Guo
patent: 2004/0029902 (2004-02-01), Singh et al.
patent: 2004/0102630 (2004-05-01), Brumby
patent: 2004/0224966 (2004-11-01), Brumby et al.
patent: 2004/0265852 (2004-12-01), Plowman et al.
patent: 2005/0002938 (2005-01-01), Plowman et al.
patent: 2005/0113398 (2005-05-01), Argade et al.
patent: 2005/0176743 (2005-08-01), Luecking et al.
patent: 2005/0192301 (2005-09-01), Li et al.
patent: 2005/0203114 (2005-09-01), Armistead et al.
patent: 2005/0209221 (2005-09-01), Nunes et al.
patent: 2005/0209224 (2005-09-01), Singh et al.
patent: 2005/0209230 (2005-09-01), Singh et al.
patent: 2005/0234049 (2005-10-01), Singh et al.
patent: 2006/0025410 (2006-02-01), Singh et al.
patent: 2006/0035891 (2006-02-01), Li et al.
patent: 2006/0035916 (2006-02-01), Singh et al.
patent: 2006/0040955 (2006-02-01), Singh et al.
patent: 2006/0058292 (2006-03-01), Singh et al.
patent: 2006/0058525 (2006-03-01), Singh et al.
patent: 2006/0135543 (2006-06-01), Singh et al.
patent: 2006/0166308 (2006-07-01), Argade
patent: 2006/0167254 (2006-07-01), Cooper et al.
patent: 2006/0270694 (2006-11-01), Wong
patent: 2007/0032514 (2007-02-01), Zahn et al.
patent: 2007/0179140 (2007-08-01), Argade et al.
patent: 2007/0299060 (2007-12-01), Li et al.
patent: 2008/0009494 (2008-01-01), Li et al.
patent: WO 95/10506 (1995-04-01), None
patent: WO 00/03032 (2000-01-01), None
patent: WO 02/04429 (2002-01-01), None
patent: WO 02/059110 (2002-08-01), None
patent: WO 02/096888 (2002-12-01), None
patent: WO 02/102313 (2002-12-01), None
patent: WO 03/002544 (2003-01-01), None
patent: WO 03/026664 (2003-04-01), None
patent: WO 03/030909 (2003-04-01), None
patent: WO 03/032997 (2003-04-01), None
patent: WO 03/040141 (2003-05-01), None
patent: WO 03/055489 (2003-07-01), None
patent: WO 01/60816 (2004-08-01), None
patent: WO 2005/035507 (2005-04-01), None
patent: WO 2005/037800 (2005-04-01), None
patent: WO 2005/063722 (2005-07-01), None
patent: WO 2005/118544 (2005-12-01), None
patent: WO 2006/078846 (2006-07-01), None
patent: WO 97/22702 (2009-06-01), None
Forro et al.: “Vapor-assisted enzymatic hydrolysis of beta-lactams in a solvent-fee system,” Tetrahedron: Asymmetry, 2008, pp. 1005-1009, vol. 19, Elsvier, Oxford, United Kingdom.
Ulrich, Chapter 4: Crystallization, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
Vippagunta et al., Crystalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
Gura, Systems for identifying New Drugs Are Often Faulty, Cancer Models, Science, vol. 278, No. 5340, pp. 1041-1042, 1997.
Johnson et al., Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials, British Journal of Cancer (2001) 64(10):1424:1431.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1010, 1996.
Rogers et al., PubMed Abstract (J Cell Biol. 157(2):219:29, Epub) Apr. 2002.
Tanaka et al. PubMed Abstract (Cell 108(3):317-29) Feb. 2002.
Cuiper, Ann Dite: “Molecular docketing with Candida Antarctica Lipase B1,” Enantioselecetive Synthesis of Lactams and Lactones: A Chemo-Enzymatic Approach, Chapter 10, 1999, pp. 133-10, http://dissertations. Ub.rug.ni/oal.
Adam et al. Synthesis of Optically Active x-Methyklene beta-lactams through lipase-catalyzed Kinetic Resolutions J. Org. Chem. 65a:4919-4922, 2000.
Forro et al.: “Direct and Indirect Enzymatic Methods for the Preparation of Enatiopure Cyclic beta-amino acids and Derivative from beta-lactams,” Mini-Reviews in Organic Chemistry, 1(1):93-102, 2004.
Kurokawa et al. Both Enantiomers of N-oc—indoline-2-carboxylic Esters, Bull, Chem. Soc. Jpn. 77L1021-1025, 2004.
Parker et al.: “Enhancement ofCandida antarctiaLipase B Eantioseleceivity and Activity in Organic Solvents,” Chem. Commun, pp. 2247-2248, 1998.
Torre et al., 2004, “Lipase Catalysed Michael Addition of Secondary Amines to Acrylonitrile,” Chem. Commun. pp. 1724-1725.
Lin-Yu Lu et al.: “Aurora A Is essential for Early Embryonic Development and Tumor Suppression,” Journal of Biological Chemistry, vol. 283, No. 46, Nov. 14, 2008, pp. 31785-31790.
Elizabeth A. Harrington et al.: “VX-680, a potent and selective small-molecule inhibitor of the aurora kinases, suppresses tumor growth in vivo,” Nature Medicine, vol. 10, No. 3, Mar. 2004, pp. 262-267.

Affiliated with

Also associated with

Rating

Cycloalkyl substituted pyrimidinediamine compounds and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cycloalkyl substituted pyrimidinediamine compounds and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkyl substituted pyrimidinediamine compounds and their... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2689984